← Insider Monitor
Skye Bioscience, Inc. logo
SKYE

Skye Bioscience, Inc.

Recent activity from public SEC and congressional filings.

18
Insider trades
0
Congress trades

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Schwab Andrew J.InsiderSell$96KAug 18, 2026
5AM Partners VII, LLCInsiderSell$96KAug 18, 2026
Schwab Andrew J.InsiderSell$20KAug 19, 2026
5AM Partners VII, LLCInsiderSell$20KAug 19, 2026
Schwab Andrew J.InsiderSell$17KAug 18, 2026
5AM Partners VII, LLCInsiderSell$17KAug 18, 2026
Schwab Andrew J.InsiderSell$4KAug 19, 2026
5AM Partners VII, LLCInsiderSell$4KAug 19, 2026
Schwab Andrew J.InsiderSell$2KAug 20, 2026
5AM Partners VII, LLCInsiderSell$2KAug 20, 2026
Schwab Andrew J.InsiderSell$695Aug 18, 2026
5AM Partners VII, LLCInsiderSell$695Aug 18, 2026
Schwab Andrew J.InsiderSell$371Aug 20, 2026
5AM Partners VII, LLCInsiderSell$371Aug 20, 2026
Schwab Andrew J.InsiderSell$143Aug 19, 2026
5AM Partners VII, LLCInsiderSell$143Aug 19, 2026
Schwab Andrew J.InsiderSell$15Aug 20, 2026
5AM Partners VII, LLCInsiderSell$15Aug 20, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for SKYE.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable SKYE activity by email

Free alerts for the insider and congressional trades worth watching.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.